XML 65 R21.htm IDEA: XBRL DOCUMENT v3.24.3
Derivative Instruments
9 Months Ended
Sep. 30, 2024
Derivative Instruments  
Derivative Instruments

13. Derivative Instruments

Derivatives Designated as Hedging Instruments

Net Investment Hedges

In September 2022, we entered into cross-currency interest rate swaps, which effectively convert a portion of our U.S. dollar-denominated fixed-rate debt to foreign currency-denominated fixed-rate debt in order to hedge the currency exposure associated with our net investment in foreign subsidiaries. As of September 30, 2024, we had cross-currency interest rate swaps outstanding with notional amounts of $1.7 billion and maturity dates ranging through 2028.

The effect of these net investment hedges on accumulated other comprehensive loss and the condensed consolidated income statements for the three and nine months ended September 30, 2024 and 2023 was as follows (in thousands):

Three Months Ended September 30, 

Nine Months Ended September 30, 

2024

    

2023

2024

    

2023

Cross-currency interest rate swaps (included component) (1)

$

(83,624)

$

52,698

$

(5,616)

$

53,853

Cross-currency interest rate swaps (excluded component) (2)

12,121

(14,006)

12,748

(28,423)

Total

$

(71,503)

$

38,692

$

7,132

$

25,430

Location of

Three Months Ended September 30, 

Nine Months Ended September 30, 

gain or (loss)

2024

    

2023

2024

    

2023

Cross-currency interest rate swaps (excluded component) (2)

Interest expense

$

5,205

$

5,505

$

17,314

$

16,699

(1)Included component represents foreign exchange spot rates.
(2)Excluded component represents cross-currency basis spread and interest rates.

Cash Flow Hedges  

As of September 30, 2024, we had derivatives designated as cash flow hedges on the Euro Term Loan Facilities (€375 million notional amount) and the USD Term Loan ($500 million notional amount). Amounts reported in Accumulated other comprehensive loss related to interest rate swaps are reclassified to interest expense as interest payments are made on our debt. As of September 30, 2024, we estimate that an additional $1.6 million will be reclassified as a decrease to interest expense during the twelve months ended September 30, 2025, when the hedged forecasted transactions impact earnings.

The effect of these cash flow hedges on accumulated other comprehensive income and the condensed consolidated income statements for the three and nine months ended September 30, 2024 and 2023 was as follows (in thousands):

Three Months Ended September 30, 

Nine Months Ended September 30, 

2024

    

2023

2024

    

2023

Interest rate swaps

$

(19,191)

$

538

$

(7,991)

$

12,912

Location of

Three Months Ended September 30, 

Nine Months Ended September 30, 

gain or (loss)

2024

    

2023

2024

    

2023

Interest rate swaps

Interest expense

$

4,031

$

3,845

$

12,348

$

6,688

Fair Value of Derivative Instruments

The subsequent table presents the fair value of derivative instruments recognized in our condensed consolidated balance sheets as of September 30, 2024 and December 31, 2023 (in thousands):

September 30, 2024

December 31, 2023

    

Assets (1)

    

Liabilities (2)

    

Assets (1)

    

Liabilities (2)

Cross-currency interest rate swaps

$

4,246

$

153,867

$

$

156,753

Interest rate swaps

7,786

16,300

8,538

$

12,032

$

170,167

$

8,538

$

156,753

(1)As presented in our condensed consolidated balance sheets within Other assets.
(2)As presented in our condensed consolidated balance sheets within Accounts payable and other accrued liabilities.